Index Overview
MSCI India Domestic World Healthcare 45
Fundamentals
| Asset Type | Equity |
| Index Type | Global |
| Std Deviation (1 yr) | 0.69% |
| Asset Type | Equity |
| Index Type | Global |
| Std Deviation (1 yr) | 0.69% |
Exchange Traded Funds (ETFs)
No exchange traded funds (etfs) available for this index
Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 189 | 0.43% | 0.81% | 1.24% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 189 | 0.43% | 0.81% | 1.24% |
Sectoral Allocation
Total
100%
allocation
- Healthcare91.2%
- Others6.9%
- Miscellaneous1.7%
- Finance0.2%
- Healthcare91.2%
- Others6.9%
- Miscellaneous1.7%
- Finance0.2%
Index Constituents
| Name | Weight |
|---|
| Sun Pharmaceutical Industries Ltd. | 11.5% |
| ELI LILLY ORD SHS | 6.5% |
| Apollo Hospitals Enterprise Ltd. | 5.8% |
| Divi's Laboratories Ltd. | 5.3% |
| Cipla Ltd. | 5.3% |
| Max Healthcare Institute Ltd. | 5.0% |
| Dr. Reddy's Laboratories Ltd. | 4.7% |
| Johnson & Johnson | 4.0% |
| Lupin Ltd. | 3.8% |
| Torrent Pharmaceuticals Ltd. | 3.5% |
| Laurus Labs Ltd. | 3.2% |
| Fortis Healthcare Ltd. | 3.0% |
| AbbVie Inc | 2.8% |
| Aurobindo Pharma Ltd. | 2.5% |
| Glenmark Pharmaceuticals Ltd. | 2.3% |
| Merck & Company Inc | 2.1% |
| Novartis AG (US) | 2.1% |
| Mankind Pharma Ltd. | 1.9% |
| Alkem Laboratories Ltd. | 1.7% |
| Biocon Ltd. | 1.7% |
| Zydus Lifesciences Ltd. | 1.4% |
| Ipca Laboratories Ltd. | 1.4% |
| Thermo Fisher Scientific Inc | 1.3% |
| Amgen | 1.3% |
| JB Chemicals & Pharmaceuticals Ltd. | 1.2% |
| Gilead Sciences Inc. | 1.2% |
| Aster DM Healthcare Ltd. | 1.1% |
| Gland Pharma Ltd. | 1.1% |
| INTUITIVE SURGICAL INC COM | 1.1% |
| Abbott Laboratories | 1.1% |
| Novo Nordisk A/S | 1.1% |
| Narayana Hrudayalaya Ltd. | 0.9% |
| Ajanta Pharma Ltd. | 0.8% |
| Danaher Corp | 0.8% |
| Vertex Pharmaceuticals Inc. | 0.8% |
| Stryker Corp | 0.8% |
| Medtronic Plc | 0.7% |
| Global Health Ltd. | 0.6% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.6% |
| Regeneron Pharmaceuticals | 0.5% |
| Emcure Pharmaceuticals Ltd. | 0.3% |
| Becton Dickinson and Co | 0.3% |
| Agilent Technologies Inc | 0.3% |
| Iqvia Holdings | 0.2% |
| Water Corp ORD SHS | 0.1% |
NameWeight
Sun Pharmaceutical Industries Ltd.11.5%
ELI LILLY ORD SHS6.5%
Apollo Hospitals Enterprise Ltd.5.8%
Divi's Laboratories Ltd.5.3%
Cipla Ltd.5.3%
Max Healthcare Institute Ltd.5.0%
Dr. Reddy's Laboratories Ltd.4.7%
Johnson & Johnson4.0%
Lupin Ltd.3.8%
Torrent Pharmaceuticals Ltd.3.5%
Laurus Labs Ltd.3.2%
Fortis Healthcare Ltd.3.0%
AbbVie Inc2.8%
Aurobindo Pharma Ltd.2.5%
Glenmark Pharmaceuticals Ltd.2.3%
Merck & Company Inc2.1%
Novartis AG (US)2.1%
Mankind Pharma Ltd.1.9%
Alkem Laboratories Ltd.1.7%
Biocon Ltd.1.7%
Zydus Lifesciences Ltd.1.4%
Ipca Laboratories Ltd.1.4%
Thermo Fisher Scientific Inc1.3%
Amgen1.3%
JB Chemicals & Pharmaceuticals Ltd.1.2%
Gilead Sciences Inc.1.2%
Aster DM Healthcare Ltd.1.1%
Gland Pharma Ltd.1.1%
INTUITIVE SURGICAL INC COM1.1%
Abbott Laboratories1.1%
Novo Nordisk A/S1.1%
Narayana Hrudayalaya Ltd.0.9%
Ajanta Pharma Ltd.0.8%
Danaher Corp0.8%
Vertex Pharmaceuticals Inc.0.8%
Stryker Corp0.8%
Medtronic Plc0.7%
Global Health Ltd.0.6%
Glaxosmithkline Pharmaceuticals Ltd.0.6%
Regeneron Pharmaceuticals0.5%
Emcure Pharmaceuticals Ltd.0.3%
Becton Dickinson and Co0.3%
Agilent Technologies Inc0.3%
Iqvia Holdings0.2%
Water Corp ORD SHS0.1%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
34.4%
34%
share
Top 6–10
5 holdings
20.9%
21%
share
Top 11–20
10 holdings
23.4%
23%
share
Beyond 20
25 holdings
21.3%
21%
share
Market Cap Classification
Total
100%
allocation
- Large Cap41.0%
- Mid Cap25.2%
- Small Cap4.7%
- Large Cap41.0%
- Mid Cap25.2%
- Small Cap4.7%
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | MSCI India Domestic IMI & MSCI World Index |
| Weightage? | Free-Float Market Cap Weighting; Max weight per stock = 20% (capped) |
| Stocks Included | 25 largest healthcare securities from MSCI India Domestic IMI and 20 largest healthcare securities from MSCI World Index, selected from healthcare sub-industries (e.g., pharmaceuticals, biotechnology, healthcare equipment, healthcare services) based on market capitalization and liquidity filters. |
| Exclusions | Securities failing liquidity filters, not classified under eligible healthcare sub-industries, or falling below ranking thresholds (top 25 India / top 20 World) during review are excluded. |
| Factor Basis | Sector/Theme |
| Universe | MSCI India Domestic IMI & MSCI World Index |
| Weightage | Free-Float Market Cap Weighting; Max weight per stock = 20% (capped) |
| Stocks Included | 25 largest healthcare securities from MSCI India Domestic IMI and 20 largest healthcare securities from MSCI World Index, selected from healthcare sub-industries (e.g., pharmaceuticals, biotechnology, healthcare equipment, healthcare services) based on market capitalization and liquidity filters. |
| Exclusions | Securities failing liquidity filters, not classified under eligible healthcare sub-industries, or falling below ranking thresholds (top 25 India / top 20 World) during review are excluded. |
Index • Last updated: 11/09/2026
Note: Above data is based on average of ETFs / Index Funds.